RANDI WRIGHT: Open Payments
NPI 1730609439 · CAVE CITY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 32 payments from 10 companies in 2025. Trend: 2023 $539 · 2024 $520 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $173 |
| Novo Nordisk Inc | 10 | $153 |
| ABBVIE INC. | 2 | $50 |
| Amgen Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $31 |
| CVRx, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Krystal Biotech Inc | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: Rybelsus, FARXIGA, AIRSUPRA, UBRELVY, OTEZLA, BREZTRI, Wegovy, MOUNJARO.
Industry payments across AR — which companies pay providers there.
